Key result
The authors question the clinical utility and safety of previously recommended rocuronium doses for electroconvulsive therapy due to unvalidated methodology and disparate recovery times.
Population
31 patients receiving electroconvulsive therapy (187 treatments)
Design
Editorial
Authors
Loading...
The authors question the clinical utility and safety of the previously published recommendations on neuromuscular blocker dosing for electroconvulsive therapy due to methodological concerns and disparities with published recovery times.
The authors question the clinical utility and safety of the previously published recommendations on neuromuscular blocker dosing for electroconvulsive therapy due to methodological concerns and disparities with published recovery times.
Kopman et al. (2016) conducted a letter in Electroconvulsive therapy (n=31). Rocuronium was evaluated. The authors question the clinical utility and safety of previously recommended rocuronium doses for electroconvulsive therapy due to unvalidated methodology and disparate recovery times.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: